Capricor Therapeutics Inc (CAPR)

[GS1]

Check clinical trials website.

Acceess type : Expanded access
Expanded access type : IND treatment protocol

Expanded Access for Widespread Use

Treatment IND: 

Access to an investigational drug (including a biologic) for treatment use by a large (widespread) population, submitted as a protocol under a new IND. The investigational product must be under active development for i. Unless FDA notifies the sponsor that treatment may begin earlier, there is a 30-day waiting period before treatment may begin.